Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coronary thrombolysis: mortality trials

J A Cairns

    The Canadian Journal of Cardiology
    |July 1, 1993
    PubMed
    Summary

    Streptokinase (SK), APSAC, and rt-PA significantly reduce early mortality in acute myocardial infarction (MI) patients. Accelerated rt-PA with heparin showed superior mortality reduction in the GUSTO trial.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cost-effectiveness of alternative changes to a national blood collection service.

    Transfusion medicine (Oxford, England)·2018
    Same author

    Pathophysiology of cardiogenic thromboembolism.

    Platelets·2010
    Same author

    Left atrial myxoma mimicking vasculitis.

    Canadian Medical Association journal·2010
    Same author

    Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids.

    BJOG : an international journal of obstetrics and gynaecology·2008
    Same author

    TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making.

    European journal of cancer (Oxford, England : 1990)·2007
    Same author

    The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks.

    The Canadian journal of cardiology·2007

    Area of Science:

    • Cardiology
    • Thrombolytic Therapy
    • Acute Myocardial Infarction Management

    Background:

    • Acute myocardial infarction (MI) poses a significant mortality risk.
    • Early reperfusion therapy is crucial for improving outcomes in acute MI.
    • Thrombolytic agents have been investigated for their efficacy in reducing MI-related mortality.

    Framework:

    • Systematic overview of Level I trials evaluating thrombolytic agents.
    • Comparison of mortality reduction across different thrombolytic therapies (SK, APSAC, rt-PA) versus placebo.
    • Long-term follow-up of early trial benefits.

    Implementation:

    • Intravenous administration of SK, APSAC, and rt-PA within hours of acute MI onset.
    • Direct comparison of mortality outcomes between different thrombolytic regimens.
    • Evaluation of accelerated rt-PA combined with heparin in the GUSTO trial.

    Implications:

    • Established efficacy of SK, APSAC, and rt-PA in reducing early and one-year mortality post-MI.
    • The GUSTO trial highlights superior outcomes with accelerated rt-PA plus heparin.
    • Evidence supports optimized thrombolytic strategies for acute MI management.

    Related Experiment Videos